Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.12.2022 | Case report

Methotrexate/tacrolimus

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Catala L, et al. Favourable evolution of a hematopoietic stem cell transplant in a cbl syndrome patient after splenectomy and immunosuppression suspension. Bone Marrow Transplantation 57 (Suppl. 1): 381-382 (plus poster) abstr. P521, Nov 2022. Available from: URL: http://doi.org/10.1038/s41409-022-01798-0 [abstract] Catala L, et al. Favourable evolution of a hematopoietic stem cell transplant in a cbl syndrome patient after splenectomy and immunosuppression suspension. Bone Marrow Transplantation 57 (Suppl. 1): 381-382 (plus poster) abstr. P521, Nov 2022. Available from: URL: http://​doi.​org/​10.​1038/​s41409-022-01798-0 [abstract]
Metadaten
Titel
Methotrexate/tacrolimus
Lack of efficacy: case report
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-29973-9

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Octreotide

Case report

Antineoplastics

Case report

Digoxin

Case report

Antineoplastics